“Katherine R. Kelly”

As a Name:  Registrant, Group Member and/or Signatory

        

Latest Filing:  4/24/24  as  ↓Signatory

        

As:  Signatory  (Director, Officer, Attorney, Accountant, Banker, Agent, etc.)

“Katherine R. Kelly” has been a Signatory for/with  3  Filers:

        

As Of	Filer			Filings       #        Latest		Issuer     (Primary)
4/24/24		CA	Meta Platforms, Inc.	35	10-Q	—
8/9/21		NJ	Bristol-Myers Squibb Co.	36	8-K	—
11/27/20		CA	MyoKardia, Inc.	9	15-12B	—

“Katherine R. Kelly” has/had a Signatory interest in  7  Issuers:

As Of	Issuer			Filings       #        Latest		With Filer     (Primary)
7/26/21		NJ	Celularity Inc.	1	SC 13G	NJ	Bristol-Myers Squibb Co.
4/5/21		CA	Sutro Biopharma, Inc.	1	SC 13G/A	NJ	Bristol-Myers Squibb Co.
4/5/21		CA	IDEAYA Biosciences, Inc.	1	SC 13G/A	NJ	Bristol-Myers Squibb Co.
4/5/21		MA	Agios Pharmaceuticals, Inc.	1	SC 13D/A	NJ	Bristol-Myers Squibb Co.
4/5/21		MA	Jounce Therapeutics, Inc.	1	SC 13G/A	NJ	Bristol-Myers Squibb Co.
4/5/21		MA	Ikena Oncology, Inc.	1	SC 13G	NJ	Bristol-Myers Squibb Co.
11/17/20		CA	MyoKardia, Inc.	5	SC 14D9/A	CA	MyoKardia, Inc.